| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.706 | 0.002 | 0.706 | 5 Hydroxytryptamine 3 antagonist | 0.36 0.004 CID_154699640 0.516 0.003 CID_154699835 0.514 0.003 CID_154700143 0.523 0.003 CID_154699622 | ||
| 0.581 | 0.004 | 0.706 | Cholinergic antagonist | 0.272 0.017 CID_154699640 0.706 0.003 CID_154699835 0.566 0.004 CID_154700143 0.561 0.004 CID_154699622 | CID_154699835 | |
| 0.578 | 0.004 | 0.707 | Acetylcholine antagonist | 0.265 0.018 CID_154699640 0.707 0.003 CID_154699835 0.565 0.004 CID_154700143 0.559 0.004 CID_154699622 | CID_154699835 | |
| 0.523 | 0.006 | 0.523 | 5 Hydroxytryptamine antagonist | 0.167 0.043 CID_154699640 0.426 0.01 CID_154699835 0.41 0.011 CID_154700143 0.433 0.01 CID_154699622 | ||
| 0.531 | 0.026 | 0.697 | Toll-Like receptor 7 agonist | 0.216 0.183 CID_154699640 0.697 0.009 CID_154699835 0.499 0.032 CID_154700143 0.515 0.029 CID_154699622 | CID_154699835 | |
| 0.525 | 0.027 | 0.691 | Toll-Like receptor agonist | 0.209 0.19 CID_154699640 0.691 0.009 CID_154699835 0.491 0.033 CID_154700143 0.508 0.03 CID_154699622 | CID_154699835 | |
| 0.492 | 0.004 | 0.495 | Acetylcholine nicotinic antagonist | 0.188 0.014 CID_154699640 0.36 0.005 CID_154699835 0.495 0.004 CID_154700143 0.48 0.004 CID_154699622 | CID_154700143 | |
| 0.487 | 0.012 | 0.487 | Psychostimulant | 0.433 0.018 CID_154699640 0.427 0.019 CID_154699835 0.477 0.013 CID_154700143 0.456 0.015 CID_154699622 | ||
| 0.439 | 0.033 | 0.458 | Spasmolytic | 0.303 0.069 CID_154699640 0.45 0.031 CID_154699835 0.451 0.031 CID_154700143 0.458 0.029 CID_154699622 | CID_154699622 | |
| 0.382 | 0.003 | 0.382 | Nicotinic receptor alpha7 subunit antagonist | 0.129 0.008 CID_154699640 0.267 0.004 CID_154699835 0.365 0.003 CID_154700143 0.331 0.003 CID_154699622 | ||
| 0.371 | 0.007 | 0.475 | Acetylcholine M1 receptor antagonist | 0.197 0.044 CID_154699640 0.475 0.004 CID_154699835 0.351 0.008 CID_154700143 0.357 0.008 CID_154699622 | CID_154699835 | |
| 0.402 | 0.045 | 0.432 | 5 Hydroxytryptamine release stimulant | 0.23 0.1 CID_154699640 0.226 0.102 CID_154699835 0.325 0.063 CID_154700143 0.432 0.039 CID_154699622 | CID_154699622 | |
| 0.408 | 0.053 | 0.45 | Vasodilator, peripheral | 0.275 0.11 CID_154699640 0.45 0.041 CID_154699835 0.366 0.067 CID_154700143 0.386 0.06 CID_154699622 | CID_154699835 | |
| 0.357 | 0.005 | 0.357 | 5 Hydroxytryptamine uptake inhibitor | 0.103 0.025 CID_154699640 0.287 0.007 CID_154699835 0.295 0.006 CID_154700143 0.302 0.006 CID_154699622 | ||
| 0.351 | 0.004 | 0.368 | Neuronal nicotinic receptor antagonist | 0.122 0.017 CID_154699640 0.258 0.006 CID_154699835 0.368 0.004 CID_154700143 0.347 0.004 CID_154699622 | CID_154700143 | |
| 0.414 | 0.072 | 0.463 | Calcium channel L-type activator | 0.406 0.077 CID_154699640 0.372 0.101 CID_154699835 0.463 0.044 CID_154700143 0.424 0.066 CID_154699622 | CID_154700143 | |
| 0.345 | 0.006 | 0.481 | Acetylcholine muscarinic antagonist | 0.156 0.04 CID_154699640 0.481 0.004 CID_154699835 0.318 0.008 CID_154700143 0.32 0.008 CID_154699622 | CID_154699835 | |
| 0.312 | 0.004 | 0.312 | Dopamine uptake inhibitor | 0.064 0.035 CID_154699640 0.202 0.006 CID_154699835 0.231 0.005 CID_154700143 0.237 0.005 CID_154699622 | ||
| 0.345 | 0.053 | 0.349 | Calcium channel activator | 0.314 0.078 CID_154699640 0.3 0.092 CID_154699835 0.349 0.05 CID_154700143 0.327 0.067 CID_154699622 | CID_154700143 | |
| 0.274 | 0.027 | 0.274 | Lipocortins synthesis antagonist | 0.249 0.034 CID_154699640 0.238 0.038 CID_154699835 0.247 0.034 CID_154700143 0.266 0.029 CID_154699622 | ||
| 0.254 | 0.008 | 0.254 | Acetylcholine agonist | 0.194 0.015 CID_154699640 0.187 0.017 CID_154699835 0.194 0.015 CID_154700143 0.189 0.016 CID_154699622 | ||
| 0.241 | 0.005 | 0.241 | Adrenaline uptake inhibitor | 0.094 0.02 CID_154699640 0.204 0.006 CID_154699835 0.207 0.005 CID_154700143 0.21 0.005 CID_154699622 | ||
| 0.241 | 0.005 | 0.378 | Acetylcholine M2 receptor antagonist | 0.378 0.004 CID_154699835 0.208 0.006 CID_154700143 0.213 0.006 CID_154699622 | CID_154699835 | |
| 0.221 | 0.004 | 0.221 | Dopamine transporter inhibitor | 0.121 0.008 CID_154699640 0.19 0.004 CID_154699835 0.196 0.004 CID_154700143 0.194 0.004 CID_154699622 | ||
| 0.33 | 0.114 | 0.384 | Antibacterial | 0.384 0.084 CID_154699835 0.339 0.109 CID_154700143 0.351 0.102 CID_154699622 | CID_154699835 | |
| 0.212 | 0.003 | 0.212 | 5 Hydroxytryptamine 3B antagonist | 0.055 0.012 CID_154699640 0.087 0.006 CID_154699835 0.11 0.004 CID_154700143 0.112 0.004 CID_154699622 | ||
| 0.212 | 0.004 | 0.212 | 5 Hydroxytryptamine 3A antagonist | 0.099 0.017 CID_154699640 0.117 0.01 CID_154699835 0.143 0.005 CID_154700143 0.142 0.005 CID_154699622 | ||
| 0.312 | 0.108 | 0.312 | Antiobesity | 0.275 0.135 CID_154699835 0.276 0.134 CID_154700143 0.275 0.135 CID_154699622 | ||
| 0.205 | 0.012 | 0.216 | Antineoplastic alkaloid | 0.079 0.066 CID_154699640 0.216 0.01 CID_154699835 0.207 0.012 CID_154700143 0.206 0.012 CID_154699622 | CID_154699835 | |
| 0.306 | 0.137 | 0.306 | Analgesic | 0.225 0.209 CID_154699835 0.284 0.155 CID_154700143 0.295 0.145 CID_154699622 | ||
| 0.208 | 0.043 | 0.647 | Cholinergic | 0.647 0.004 CID_154699640 0.194 0.049 CID_154699835 0.197 0.048 CID_154700143 0.211 0.042 CID_154699622 | CID_154699640 | |
| 0.239 | 0.075 | 0.27 | DNA synthesis inhibitor | 0.249 0.067 CID_154699640 0.27 0.055 CID_154699835 0.241 0.073 CID_154700143 0.24 0.073 CID_154699622 | CID_154699835 | |
| 0.177 | 0.013 | 0.193 | Prolactin inhibitor | 0.123 0.036 CID_154699640 0.132 0.031 CID_154699835 0.172 0.015 CID_154700143 0.193 0.01 CID_154699622 | CID_154699622 | |
| 0.333 | 0.171 | 0.333 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.162 | 0.005 | 0.162 | Glycine receptor antagonist | 0.138 0.01 CID_154699640 0.108 0.026 CID_154699835 0.128 0.014 CID_154700143 0.128 0.014 CID_154699622 | ||
| 0.167 | 0.011 | 0.168 | Acetylcholine M3 receptor agonist | 0.108 0.041 CID_154699640 0.168 0.011 CID_154699835 0.158 0.015 CID_154700143 0.155 0.017 CID_154699622 | CID_154699835 | |
| 0.163 | 0.01 | 0.295 | Acetylcholine M3 receptor antagonist | 0.075 0.028 CID_154699640 0.295 0.004 CID_154699835 0.173 0.009 CID_154700143 0.164 0.01 CID_154699622 | CID_154699835 | |
| 0.16 | 0.009 | 0.16 | Acetylcholine M4 receptor antagonist | 0.091 0.036 CID_154699640 0.121 0.017 CID_154699835 0.112 0.021 CID_154700143 0.115 0.019 CID_154699622 | ||
| 0.158 | 0.015 | 0.158 | Acetylcholine nicotinic agonist | 0.093 0.043 CID_154699640 0.109 0.031 CID_154699835 0.147 0.018 CID_154700143 0.139 0.02 CID_154699622 | ||
| 0.234 | 0.093 | 0.234 | Cardiotonic | 0.213 0.107 CID_154699835 0.2 0.119 CID_154700143 0.209 0.111 CID_154699622 | ||
| 0.143 | 0.004 | 0.143 | 5 Hydroxytryptamine 4 antagonist | 0.071 0.017 CID_154699640 0.114 0.005 CID_154699835 0.121 0.004 CID_154700143 0.12 0.004 CID_154699622 | ||
| 0.231 | 0.096 | 0.252 | 5 Hydroxytryptamine 1E antagonist | 0.214 0.115 CID_154700143 0.252 0.073 CID_154699622 | CID_154699622 | |
| 0.134 | 0.004 | 0.134 | Nicotinic alpha3beta2 receptor antagonist | 0.134 0.004 CID_154699640 0.083 0.012 CID_154699835 0.084 0.011 CID_154700143 0.088 0.01 CID_154699622 | ||
| 0.251 | 0.127 | 0.292 | Sodium/bile acid cotransporter inhibitor | 0.21 0.175 CID_154699640 0.269 0.109 CID_154699835 0.278 0.1 CID_154700143 0.292 0.086 CID_154699622 | CID_154699622 | |
| 0.208 | 0.088 | 0.234 | Cyclic AMP phosphodiesterase inhibitor | 0.161 0.134 CID_154699835 0.197 0.096 CID_154700143 0.234 0.072 CID_154699622 | CID_154699622 | |
| 0.292 | 0.178 | 0.346 | Apoptosis agonist | 0.314 0.162 CID_154699835 0.345 0.142 CID_154700143 0.346 0.141 CID_154699622 | CID_154699622 | |
| 0.124 | 0.013 | 0.124 | Acetylcholine muscarinic agonist | 0.07 0.027 CID_154699640 0.071 0.026 CID_154699835 0.056 0.037 CID_154700143 0.059 0.034 CID_154699622 | ||
| 0.185 | 0.075 | 0.193 | P-glycoprotein inhibitor | 0.174 0.086 CID_154699835 0.182 0.078 CID_154700143 0.193 0.069 CID_154699622 | CID_154699622 | |
| 0.142 | 0.037 | 0.145 | Protein kinase C gamma inhibitor | 0.134 0.042 CID_154700143 0.145 0.035 CID_154699622 | CID_154699622 | |
| 0.199 | 0.095 | 0.223 | Angiogenesis stimulant | 0.155 0.119 CID_154699640 0.176 0.107 CID_154699835 0.212 0.088 CID_154700143 0.223 0.083 CID_154699622 | CID_154699622 | |
| 0.132 | 0.03 | 0.132 | Protein kinase C delta inhibitor | 0.106 0.047 CID_154699640 0.109 0.044 CID_154699835 0.124 0.035 CID_154700143 0.127 0.033 CID_154699622 | ||
| 0.163 | 0.061 | 0.192 | NOS3 expression enhancer | 0.14 0.084 CID_154699640 0.148 0.074 CID_154699835 0.176 0.052 CID_154700143 0.192 0.044 CID_154699622 | CID_154699622 | |
| 0.113 | 0.014 | 0.179 | Acetylcholine M5 receptor antagonist | 0.054 0.051 CID_154699640 0.179 0.005 CID_154699835 0.079 0.025 CID_154700143 0.087 0.022 CID_154699622 | CID_154699835 | |
| 0.113 | 0.014 | 0.114 | Protein kinase C eta inhibitor | 0.075 0.026 CID_154699640 0.088 0.02 CID_154699835 0.111 0.014 CID_154700143 0.114 0.014 CID_154699622 | CID_154699622 | |
| 0.13 | 0.039 | 0.229 | Bronchodilator | 0.087 0.078 CID_154699640 0.229 0.015 CID_154699835 0.143 0.034 CID_154700143 0.153 0.03 CID_154699622 | CID_154699835 | |
| 0.1 | 0.012 | 0.1 | Acetylcholine M1 receptor agonist | 0.049 0.026 CID_154699640 0.037 0.036 CID_154700143 | ||
| 0.144 | 0.058 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.133 0.104 CID_154699640 0.132 0.111 CID_154699835 0.134 0.099 CID_154700143 0.135 0.093 CID_154699622 | ||
| 0.136 | 0.055 | 0.138 | Adenylate cyclase inhibitor | 0.093 0.091 CID_154699835 0.12 0.068 CID_154700143 0.138 0.054 CID_154699622 | CID_154699622 | |
| 0.108 | 0.029 | 0.111 | Somatostatin 1 agonist | 0.084 0.047 CID_154699640 0.096 0.037 CID_154699835 0.111 0.027 CID_154700143 0.111 0.027 CID_154699622 | CID_154699622 | |
| 0.102 | 0.03 | 0.102 | Nicotinic alpha4beta2 receptor antagonist | 0.074 0.057 CID_154699640 0.07 0.062 CID_154699835 0.088 0.042 CID_154700143 0.077 0.053 CID_154699622 | ||
| 0.114 | 0.049 | 0.114 | Adenylate kinase inhibitor | 0.098 0.07 CID_154699640 | ||
| 0.071 | 0.007 | 0.071 | Farnesoid X receptor agonist | 0.046 0.018 CID_154699835 0.049 0.015 CID_154700143 0.054 0.012 CID_154699622 | ||
| 0.083 | 0.019 | 0.083 | Nicotinic neuronal receptor agonist | 0.049 0.046 CID_154699835 0.07 0.028 CID_154700143 0.064 0.032 CID_154699622 | ||
| 0.083 | 0.026 | 0.083 | Protein kinase C beta inhibitor | 0.064 0.06 CID_154699835 0.076 0.037 CID_154700143 0.079 0.031 CID_154699622 | ||
| 0.111 | 0.058 | 0.12 | AMP-activated protein kinase stimulant | 0.09 0.085 CID_154699835 0.11 0.058 CID_154700143 0.12 0.049 CID_154699622 | CID_154699622 | |
| 0.078 | 0.025 | 0.093 | Androgen agonist | 0.079 0.025 CID_154700143 0.093 0.018 CID_154699622 | CID_154699622 | |
| 0.072 | 0.02 | 0.072 | Prolactin release inhibitor | 0.068 0.026 CID_154699640 0.064 0.036 CID_154699835 0.07 0.023 CID_154700143 0.071 0.021 CID_154699622 | ||
| 0.136 | 0.088 | 0.15 | Adenylate cyclase stimulant | 0.128 0.106 CID_154699835 0.139 0.083 CID_154700143 0.15 0.063 CID_154699622 | CID_154699622 | |
| 0.158 | 0.113 | 0.196 | Antimitotic | 0.154 0.118 CID_154699835 0.196 0.086 CID_154700143 0.187 0.092 CID_154699622 | CID_154700143 | |
| 0.094 | 0.053 | 0.119 | Opioid antagonist | 0.094 0.052 CID_154699835 0.113 0.039 CID_154700143 0.119 0.037 CID_154699622 | CID_154699622 | |
| 0.064 | 0.024 | 0.064 | Acetylcholine M2 receptor agonist | 0.055 0.035 CID_154699835 0.058 0.031 CID_154700143 0.056 0.034 CID_154699622 | ||
| 0.058 | 0.023 | 0.058 | Nicotinic receptor alpha4 subunit antagonist | 0.048 0.036 CID_154699640 0.052 0.03 CID_154699835 0.057 0.024 CID_154700143 0.055 0.025 CID_154699622 | ||
| 0.216 | 0.18 | 0.216 | Immunosuppressant | 0.201 0.196 CID_154699835 0.209 0.187 CID_154700143 0.216 0.18 CID_154699622 | ||
| 0.164 | 0.13 | 0.164 | Platelet antagonist | 0.151 0.144 CID_154699835 0.151 0.144 CID_154699622 | ||
| 0.041 | 0.008 | 0.041 | Protein kinase C beta I inhibitor | 0.037 0.013 CID_154699640 0.039 0.01 CID_154699835 0.04 0.009 CID_154700143 0.041 0.008 CID_154699622 | ||
| 0.104 | 0.071 | 0.114 | 5 Hydroxytryptamine 3A agonist | 0.114 0.061 CID_154699622 | CID_154699622 | |
| 0.037 | 0.005 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.017 CID_154699640 0.036 0.005 CID_154699835 0.037 0.005 CID_154700143 0.037 0.005 CID_154699622 | ||
| 0.084 | 0.052 | 0.102 | Opioid kappa receptor antagonist | 0.087 0.049 CID_154699835 0.098 0.037 CID_154700143 0.102 0.033 CID_154699622 | CID_154699622 | |
| 0.06 | 0.031 | 0.06 | Acetyl-CoA transferase 2 inhibitor | 0.059 0.033 CID_154699835 0.058 0.036 CID_154700143 0.057 0.038 CID_154699622 | ||
| 0.206 | 0.178 | 0.215 | Interleukin 2 agonist | 0.202 0.186 CID_154699835 0.209 0.175 CID_154700143 0.215 0.165 CID_154699622 | CID_154699622 | |
| 0.052 | 0.024 | 0.052 | Nicotinic receptor alpha3 subunit antagonist | 0.045 0.03 CID_154700143 0.045 0.029 CID_154699622 | ||
| 0.071 | 0.046 | 0.071 | 5 Hydroxytryptamine agonist | |||
| 0.073 | 0.049 | 0.073 | Glycine receptor agonist | |||
| 0.164 | 0.14 | 0.185 | Tumour necrosis factor alpha release inhibitor | 0.173 0.131 CID_154700143 0.185 0.122 CID_154699622 | CID_154699622 | |
| 0.043 | 0.02 | 0.043 | Nicotinic receptor beta4 subunit antagonist | 0.037 0.026 CID_154699640 0.039 0.024 CID_154699835 0.041 0.022 CID_154700143 0.043 0.02 CID_154699622 | ||
| 0.105 | 0.083 | 0.105 | Microtubule formation inhibitor | 0.102 0.087 CID_154700143 | ||
| 0.126 | 0.107 | 0.145 | Sigma receptor agonist | 0.145 0.088 CID_154700143 0.14 0.093 CID_154699622 | CID_154700143 | |
| 0.04 | 0.021 | 0.04 | Nociceptin (N/OFQ) receptor antagonist | 0.031 0.028 CID_154699835 0.031 0.028 CID_154700143 0.033 0.026 CID_154699622 | ||
| 0.035 | 0.017 | 0.035 | Acetylcholine M4 receptor agonist | |||
| 0.028 | 0.01 | 0.028 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 CID_154699622 | ||
| 0.097 | 0.08 | 0.102 | Nav1.4 sodium channel blocker | 0.102 0.073 CID_154700143 0.102 0.073 CID_154699622 | CID_154699622 | |
| 0.035 | 0.018 | 0.035 | Protein kinase C beta II inhibitor | 0.032 0.023 CID_154699835 0.034 0.02 CID_154700143 0.035 0.018 CID_154699622 | ||
| 0.048 | 0.031 | 0.048 | Microtubule stabilization | 0.042 0.039 CID_154699640 0.044 0.036 CID_154699835 0.045 0.034 CID_154700143 0.045 0.034 CID_154699622 | ||
| 0.037 | 0.021 | 0.037 | Somatostatin 5 agonist | 0.033 0.026 CID_154700143 0.034 0.025 CID_154699622 | ||
| 0.126 | 0.111 | 0.126 | Growth hormone agonist | 0.125 0.113 CID_154700143 0.125 0.113 CID_154699622 | ||
| 0.043 | 0.028 | 0.043 | Cholecystokinin antagonist | |||
| 0.04 | 0.026 | 0.04 | Substance P antagonist | 0.035 0.033 CID_154699640 | ||
| 0.041 | 0.027 | 0.041 | Neurokinin 1 antagonist | |||
| 0.052 | 0.039 | 0.052 | Nicotinic alpha7 receptor agonist | |||
| 0.032 | 0.019 | 0.032 | Dipeptidyl peptidase I inhibitor | |||
| 0.196 | 0.184 | 0.22 | Apoptosis antagonist | 0.199 0.18 CID_154699835 0.218 0.158 CID_154700143 0.22 0.156 CID_154699622 | CID_154699622 | |
| 0.048 | 0.037 | 0.048 | Neurokinin antagonist | |||
| 0.036 | 0.027 | 0.036 | Cholecystokinin A antagonist | |||
| 0.097 | 0.089 | 0.145 | DNA polymerase I inhibitor | 0.145 0.052 CID_154699835 0.118 0.07 CID_154700143 0.118 0.07 CID_154699622 | CID_154699835 | |
| 0.092 | 0.084 | 0.111 | Beta glucuronidase inhibitor | 0.109 0.058 CID_154700143 0.111 0.055 CID_154699622 | CID_154699622 | |
| 0.046 | 0.04 | 0.046 | 5 Hydroxytryptamine 1 agonist | |||
| 0.083 | 0.079 | 0.095 | Protein kinase C zeta inhibitor | 0.089 0.067 CID_154700143 0.095 0.057 CID_154699622 | CID_154699622 | |
| 0.034 | 0.031 | 0.034 | Somatostatin 1 antagonist | 0.034 0.031 CID_154700143 0.033 0.032 CID_154699622 | ||
| 0.186 | 0.183 | 0.188 | 5 Hydroxytryptamine uptake stimulant | 0.188 0.178 CID_154699835 | CID_154699835 | |
| 0.027 | 0.025 | 0.027 | Cholecystokinin B antagonist | |||
| 0.045 | 0.05 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.048 0.042 CID_154700143 0.05 0.039 CID_154699622 | CID_154699622 | |
| 0.124 | 0.134 | 0.13 | CF transmembrane conductance regulator agonist | 0.13 0.119 CID_154700143 0.127 0.125 CID_154699622 | CID_154700143 | |
| 0.052 | 0.062 | 0.055 | Lipocortins synthesis agonist | 0.055 0.047 CID_154699622 | CID_154699622 | |
| 0.086 | 0.099 | 0.122 | Anesthetic local | 0.122 0.065 CID_154699835 | CID_154699835 | |
| 0.061 | 0.078 | 0.076 | Analgesic, opioid | 0.072 0.059 CID_154700143 0.076 0.053 CID_154699622 | CID_154699622 | |
| 0.247 | 0.27 | 0.281 | Antiinflammatory | 0.281 0.234 CID_154699622 | CID_154699622 | |
| 0.047 | 0.072 | 0.069 | Opioid mu receptor antagonist | 0.064 0.05 CID_154700143 0.069 0.047 CID_154699622 | CID_154699622 | |
| 0.141 | 0.17 | 0.158 | Vasodilator | 0.155 0.149 CID_154700143 0.158 0.146 CID_154699622 | CID_154699622 | |
| 0.067 | 0.097 | 0.086 | MAP kinase kinase 7 inhibitor | 0.076 0.059 CID_154700143 0.086 0.033 CID_154699622 | CID_154699622 | |
| 0.17 | 0.202 | 0.24 | Transcription factor NF kappa B inhibitor | 0.23 0.142 CID_154700143 0.24 0.135 CID_154699622 | CID_154699622 | |
| 0.117 | 0.153 | 0.132 | Antipruritic | 0.132 0.119 CID_154699835 | CID_154699835 | |
| 0.053 | 0.093 | 0.068 | Beta 2 adrenoreceptor agonist | 0.068 0.024 CID_154699835 0.061 0.046 CID_154700143 0.058 0.057 CID_154699622 | CID_154699835 | |
| 0.073 | 0.115 | 0.091 | Anabolic | 0.091 0.076 CID_154699622 | CID_154699622 | |
| 0.11 | 0.154 | 0.136 | Nitric oxide antagonist | 0.136 0.111 CID_154699640 0.131 0.118 CID_154700143 0.136 0.11 CID_154699622 | CID_154699622 | |
| 0.115 | 0.163 | 0.152 | Hepatoprotectant | 0.152 0.107 CID_154699640 0.136 0.126 CID_154699622 | CID_154699640 | |
| 0.082 | 0.138 | 0.108 | Cyclooxygenase 3 inhibitor | 0.108 0.092 CID_154699622 | CID_154699622 | |
| 0.051 | 0.118 | 0.104 | Adrenaline agonist | 0.104 0.034 CID_154699835 0.076 0.063 CID_154700143 | CID_154699835 | |
| 0.106 | 0.178 | 0.136 | Interleukin antagonist | 0.136 0.129 CID_154700143 | CID_154700143 | |
| 0.099 | 0.189 | 0.13 | Melanin inhibitor | 0.13 0.115 CID_154699622 | CID_154699622 | |
| 0.031 | 0.127 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.04 CID_154699835 | CID_154699835 | |
| 0.117 | 0.216 | 0.189 | Antioxidant | 0.172 0.14 CID_154699835 0.178 0.134 CID_154700143 0.189 0.123 CID_154699622 | CID_154699622 | |
| 0.107 | 0.206 | 0.127 | MAP kinase kinase 4 inhibitor | 0.127 0.126 CID_154699622 | CID_154699622 | |
| 0.099 | 0.229 | 0.175 | Free radical scavenger | 0.153 0.141 CID_154699835 0.16 0.133 CID_154700143 0.175 0.119 CID_154699622 | CID_154699622 | |
| 0.026 | 0.21 | 0.072 | Transcription factor AP-1 inhibitor | 0.072 0.028 CID_154699640 | CID_154699640 | |
| 0.045 | 0.324 | 0.102 | Estrogen antagonist | 0.102 0.093 CID_154700143 0.102 0.092 CID_154699622 | CID_154699622 | |
| 0.034 | 0.653 | 0.086 | Transforming growth factor beta 3 antagonist | 0.086 0.046 CID_154699640 | CID_154699640 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |